guidelines

breast lump and nipple symptoms (recognition + 2ww referral)

gp-first assessment of breast lumps, nipple symptoms and skin changes, with nice ng12 suspected-cancer referral triggers and practical safety-netting.

last reviewed: 2026-02-13
based on: NICE NG12 (Suspected cancer: recognition and referral) + local breast “triple assessment” pathways (accessed Feb 2026).

Executive summary (what to do today)

Breast presentations are common in primary care; most are benign, but timely referral matters when NG12 criteria are met. The NHS breast clinic model is typically triple assessment: clinical assessment + imaging + biopsy where indicated.

  • 2-week-wait (NG12): aged ≥30 with an unexplained breast lump (with or without pain).
  • 2-week-wait (NG12): aged ≥50 with unilateral nipple discharge, unilateral nipple retraction, or other unilateral nipple changes of concern.
  • Don’t miss: inflammatory breast cancer (rapid onset erythema/oedema), Paget disease (eczema-like nipple change not resolving), a new axillary lump, or a suspicious male breast mass.

Primary care assessment (focused and fast)

  • History: duration, change over time, cyclical pain, pregnancy/lactation, trauma, infection symptoms, nipple discharge (spontaneous vs expressed; unilateral vs bilateral; blood-stained), systemic symptoms.
  • Risk context: age, prior breast cancer, prior chest irradiation, family history / known pathogenic variants, HRT use, alcohol, BMI.
  • Exam: inspect (asymmetry, tethering, peau d’orange, ulceration), palpate lump (size, texture, mobility), check axillary/supraclavicular nodes, examine nipple/areola.

Benign-leaning patterns (still safety-net): diffuse bilateral cyclical mastalgia, symmetrical nodularity, clear discharge only on expression, classic sebaceous cyst.

Common presentations and practical actions

  • Breast pain only (no lump): consider musculoskeletal causes; consider non-urgent imaging if focal persistent pain in older patients per local pathway.
  • Suspected mastitis/abscess (esp. lactation): treat and review; urgent same-day if systemic illness, spreading cellulitis, or suspected abscess requiring drainage.
  • Nipple discharge: red flags include spontaneous, unilateral, single-duct, blood-stained discharge; consider NG12 threshold at age ≥50 for unilateral discharge/retraction/changes.
  • Male breast symptoms: gynaecomastia is common and usually bilateral; unilateral hard subareolar mass, skin/nipple changes, or bloody discharge (often age ≥50) should be referred urgently via local suspected cancer pathways.

Safety-netting and “don’t wait” triggers

  • Immediate / urgent escalation: rapidly progressive swelling/erythema (inflammatory cancer vs severe infection), systemic sepsis, or suspected abscess needing drainage.
  • Re-review if: symptoms persist beyond 4–6 weeks, a “cyst” changes character, new axillary lump appears, or a presumed dermatitis of the nipple/areola does not respond to treatment.
  • Document: size/location (clock face + distance from nipple), node findings, and explicit safety-net advice.

FAQ

Transparency

This page is an educational, clinician-written summary of publicly available NICE guidance intended for trained healthcare professionals. It uses original wording (not copied text) and should be used alongside the full NICE source, local pathways, and clinical judgement. Doses provided are for general reference; always check the BNF/SPC.